These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9878921)

  • 1. [Pharmacovigilance: a necessary tool].
    Coêlho HL
    Cad Saude Publica; 1998; 14(4):871-5. PubMed ID: 9878921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for definitions in pharmacovigilance.
    Lindquist M
    Drug Saf; 2007; 30(10):825-30. PubMed ID: 17867720
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
    Poirot E; Soble A; Ntshalintshali N; Mwandemele A; Mkhonta N; Malambe C; Vilakati S; Pan S; Darteh S; Maphalala G; Brown J; Hwang J; Pace C; Stergachis A; Vittinghoff E; Kunene S; Gosling R
    Malar J; 2016 Jul; 15(1):384. PubMed ID: 27450652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal selection and follow-up in pharmacovigilance.
    Meyboom RH; Lindquist M; Egberts AC; Edwards IR
    Drug Saf; 2002; 25(6):459-65. PubMed ID: 12071784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monitoring medicines project: a multinational pharmacovigilance and public health project.
    Pal SN; Olsson S; Brown EG
    Drug Saf; 2015 Apr; 38(4):319-28. PubMed ID: 25829215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterinary pharmacovigilance in India: A need of hour.
    Kumar R; Kalaiselvan V; Verma R; Kaur I; Kumar P; Singh GN
    Indian J Pharmacol; 2017; 49(1):2-3. PubMed ID: 28458414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance: Importance, concepts, and processes.
    Kumar A
    Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacovigilance and post-black market surveillance.
    Langlitz N
    Soc Stud Sci; 2009 Jun; 39(3):395-420. PubMed ID: 19848184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of Vigimed, a global e-mail system for the exchange of pharmacovigilance information.
    Johansson K; Olsson S; Hellman B; Meyboom RH
    Drug Saf; 2007; 30(10):883-9. PubMed ID: 17867725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacovigilance: healthcare professionals' role in benefits versus harm analysis of drugs use.
    Gossell-Williams M
    West Indian Med J; 2010 Jan; 59(1):73-5. PubMed ID: 20931918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study.
    Schutte T; Tichelaar J; Reumerman MO; van Eekeren R; Rolfes L; van Puijenbroek EP; Richir MC; van Agtmael MA
    Drug Saf; 2017 May; 40(5):409-418. PubMed ID: 28120270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles of signal detection in pharmacovigilance.
    Meyboom RH; Egberts AC; Edwards IR; Hekster YA; de Koning FH; Gribnau FW
    Drug Saf; 1997 Jun; 16(6):355-65. PubMed ID: 9241490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance and new essential drugs in Africa: Zambia draws lessons from its own experiences and beyond.
    Huff-Rousselle M; Simooya O; Kabwe V; Hollander I; Handema R; Mwango A; Mwape E
    Glob Public Health; 2007; 2(2):184-203. PubMed ID: 19280399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the dose, time, susceptibility (DoTS) classification scheme for adverse drug reactions in pharmacovigilance planning.
    Callréus T
    Drug Saf; 2006; 29(7):557-66. PubMed ID: 16808549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmarketing pharmacovigilance: Remdesivir and cardiovascular events.
    Sullivan JT
    Clin Transl Sci; 2022 Apr; 15(4):813-815. PubMed ID: 35303401
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse events following immunization: is this time for the use of WHO causality assessment?
    Tafuri S; Gallone MS; Calabrese G; Germinario C
    Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ceará State Pharmacovigilance System: a year of experience].
    Coêlho HL; Arrais PS; Gomes AP
    Cad Saude Publica; 1999; 15(3):631-40. PubMed ID: 10502160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution and key elements of the Brazilian pharmacovigilance system: a scoping review beginning with the creation of the Brazilian Health Regulatory Agency.
    Mota DM; Vigo Á; Kuchenbecker RS
    Cad Saude Publica; 2018 Oct; 34(10):e00000218. PubMed ID: 30328994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new pharmacovigilance legislation in practice].
    Broekmans AW; Mol PG
    Ned Tijdschr Geneeskd; 2014; 158():A7129. PubMed ID: 24846112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updating the French method for the causality assessment of adverse drug reactions.
    Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
    Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.